You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations.
Click “OK” to confirm you are a Healthcare Professional.
Ablation Products for Atrial Fibrillation
The Arctic™ Front Advance and Arctic Front Advance Pro™ Cardiac Cryoablation Catheters are approved to treat drug refractory, recurrent, symptomatic, paroxysmal and persistent atrial fibrillation (episode duration less than 6 months). The Arctic™ Front Advance and Arctic Front Advance Pro™ Cardiac Cryoablation Catheters are also approved to treat recurrent, symptomatic, paroxysmal atrial fibrillation as an alternative to anti-arrhythmic drug therapy as an initial rhythm control strategy.
The catheters have a proven safety and efficacy profile in treating AF.2
Indications, Safety, and Warnings
Product DetailsThe Achieve™ and Achieve Advance™ Mapping Catheters are intra-cardiac electrophysiology diagnostic catheters designed for use with the Arctic Front family of cardiac cryoablation catheters and the FlexCath Contour™ Steerable Sheath.
Indications, Safety, and Warnings
Product DetailsThe Freezor™ family of cardiac cryoablation catheters are flexible, single-use, minimally invasive devices designed to ablate cardiac tissue. They are the only focal catheters that utilize the cryo energy source, with ablation indications ranging from atrioventricular nodal reentry tachycardia (AVNRT) to atrial arrhythmias.
Indications, Safety, and Warnings
Product DetailsAs the only open-irrigated RF catheter with industrial diamonds to optimize power based on tissue surface temperature, the DiamondTemp™ ablation system (DTA) with RealTemp™ is safe and effective, and has demonstrated procedural efficiencies compared to contact force-sensing RF.1
Indications, Safety, and Warnings
Product DetailsFlexCath Contour™ steerable sheaths enable electrophysiologists to steer therapy with confidence. Enhanced maneuverability, refined transitions, and the zero exchange workflow are experienced throughout each ablation procedure.
Indications, Safety, and Warnings
Product DetailsThe PulseSelect™ pulsed field ablation (PFA) system is a cardiac ablation system that enables both mapping and precise lesion delivery using biphasic waveform optimization.
Indications, Safety, and Warnings
Product DetailsThe FlexCath Cross™ system is an integrated transseptal solution with a zero exchange workflow and pairs with commercially available sheaths for both mechanical and radiofrequency (RF) crossing.
Indications, Safety, and Warnings
Product DetailsThe Nitron CryoConsole system houses the electrical and mechanical components as well as proprietary software for cryomapping, controlling, and recording a cryotherapy procedure performed with the Arctic Front or Freezor™ family of cryoablation catheters. Multiple features are built into the Medtronic cryoablation catheters and the Nitron CryoConsole system to promote system safety and efficiency.
Indications, Safety, and Warnings
Product DetailsAffera™ Mapping and Ablation System All-in-one - map, ablate, validate
Kautzner J, Albenque JP, Natale A, et al. A Novel Temperature-Controlled Radiofrequency Catheter Ablation System Used to Treat Patients With Paroxysmal Atrial Fibrillation. JACC Clin Electrophysiol. March 2021;7(3):352–363.
Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. April 23, 2013;61(16):1713–1723.